Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2020 | MPNs at EHA 2020: what to look out for

Claire Harrison • 4 Jun 2020
EHA 2020
Myelofibrosis Antibodies Mepolizumab Parsaclisib Pelabresib Ruxolitinib

Claire Harrison, MD, DM, FRCP, FRCPath, of Guy’s and St Thomas’ NHS Foundation Trust, London, UK, discusses the key myeloproliferative neoplasms (MPNs) data to look out for at EHA 2020. Specifically mentioned are novel therapies and pitfalls in MPNs, parsaclisib and mepolizumab for hypereosinophilic syndrome. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

More from Claire Harrison

Novel agents and approaches being explored in second-line myelofibrosis
14:29
Novel agents and approaches being explored in second-line myelofibrosis
Claire Harrison et al. • 2 Oct 2026
Reflecting on progress in MPN research and care: a lifetime perspective
2:01
Reflecting on progress in MPN research and care: a lifetime perspective
Claire Harrison • 13 Jun 2026
Updated data with INCA033989, a mutant CALR-specific mAb, in patients with MPNs
3:58
Updated data with INCA033989, a mutant CALR-specific mAb, in patients with MPNs
Claire Harrison • 13 Jun 2026
The Phase III SENTRY trial: selinexor plus ruxolitinib in JAK inhibitor-naïve myelofibrosis
2:41
The Phase III SENTRY trial: selinexor plus ruxolitinib in JAK inhibitor-naïve myelofibrosis
Claire Harrison • 13 Jun 2026

Related Videos

When to switch JAK inhibitor therapy in myelofibrosis
1:08
When to switch JAK inhibitor therapy in myelofibrosis
John Mascarenhas • 1 Oct 2026
Long-term spleen response with combination therapy in myelofibrosis: MANIFEST-2
1:36
Long-term spleen response with combination therapy in myelofibrosis: MANIFEST-2
John Mascarenhas • 1 Oct 2026
Emerging therapeutic strategies and future directions in MPNs
3:00
Emerging therapeutic strategies and future directions in MPNs
Lucia Masarova • 4 Oct 2026
MPN Progression Registry: insights into the work of the MPN Research Foundation
19:15
MPN Progression Registry: insights into the work of the MPN Research Foundation
David Shoultz et al. • 2 Oct 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals